title: In reply to 'Beneficial effect of eculizumab on thrombotic microangiopathies: another point of view'.
authors.affiliation: Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
authors.forename: Jan
authors.initials: J
authors.lastname: Schmidtko
authors.affiliation: Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: Sven
authors.initials: S
authors.lastname: Peine
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy*; D006801:Humans; D057049:Thrombotic Microangiopathies / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized